Influence of Cell Physiological State on Gene Delivery to T Lymphocytes by Chimeric Adenovirus Ad5F35

Overview

Journal Sci Rep

Specialty Science

Date 2016 Mar 15

PMID 26972139

Citations 6

Authors

Wen-Feng Zhang

Hong-Wei Shao

Feng-Lin Wu

Xin Xie

Zhu-Ming Li

Hua-Ben Bo

Han Shen

Teng Wang

Shu-Lin Huang

Affiliations

Soon will be listed here.

Abstract

Adoptive transfer of genetically-modified T cells is a promising approach for treatment of both human malignancies and viral infections. Due to its ability to efficiently infect lymphocytes, the chimeric adenovirus Ad5F35 is potentially useful as an immunotherapeutic for the genetic modification of T cells. In previous studies, it was found that the infection efficiency of Ad5F35 was significantly increased without enhanced expression of the viral receptor after T cell stimulation; however, little is known about the underlying mechanism. Nonetheless, cell physiology has long been thought to affect viral infection. Therefore, we aimed to uncover the physiologic changes responsible for the increased infection efficiency of Ad5F35 following T cell stimulation. Given the complexity of intracellular transport we analyzed viral binding, entry, and escape using a Jurkat T cell model and found that both cell membrane fluidity and endosomal escape of Ad5F35 were altered under different physiological states. This, in turn, resulted in differences in the amount of virus entering cells and reaching the cytoplasm. These results provide additional insight into the molecular mechanisms underlying Ad5F35 infection of T cells and consequently, will help further the clinical application of genetically-modified T cells for immunotherapy.

Citing Articles

Designing molecules: directing stem cell differentiation.

Thanaskody K, Natashah F, Nordin F, Wan Kamarul Zaman W, Tye G Front Bioeng Biotechnol. 2024; 12:1396405.

PMID: 38803845 PMC: 11129639. DOI: 10.3389/fbioe.2024.1396405.

Efficient Editing of an Adenoviral Vector Genome with CRISPR/Cas9.

Li Q, Wang H, Gong C, Chen Z, Yang J, Shao H Indian J Microbiol. 2021; 61(1):91-95.

PMID: 33505098 PMC: 7810804. DOI: 10.1007/s12088-020-00905-3.

Distribution and Co-localization of endosome markers in cells.

Shearer L, Petersen N Heliyon. 2019; 5(9):e02375.

PMID: 31687537 PMC: 6819826. DOI: 10.1016/j.heliyon.2019.e02375.

Gene Therapy Leaves a Vicious Cycle.

Goswami R, Subramanian G, Silayeva L, Newkirk I, Doctor D, Chawla K Front Oncol. 2019; 9:297.

PMID: 31069169 PMC: 6491712. DOI: 10.3389/fonc.2019.00297.

Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells.

Jin P, Chen W, Ren J, Chen S, Wood L, Zhao Y Cytotherapy. 2018; 20(5):728-739.

PMID: 29655599 PMC: 6014594. DOI: 10.1016/j.jcyt.2018.03.001.

References

Miyazawa N, Crystal R, Leopold P . Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. J Virol. 2001; 75(3):1387-400. PMC: 114045. DOI: 10.1128/JVI.75.3.1387-1400.2001. View

Drouin M, Cayer M, Jung D . Adenovirus 5 and chimeric adenovirus 5/F35 employ distinct B-lymphocyte intracellular trafficking routes that are independent of their cognate cell surface receptor. Virology. 2010; 401(2):305-13. DOI: 10.1016/j.virol.2010.03.003. View

Ngo M, Rooney C, Howard J, Heslop H . Ex vivo gene transfer for improved adoptive immunotherapy of cancer. Hum Mol Genet. 2011; 20(R1):R93-9. PMC: 3095061. DOI: 10.1093/hmg/ddr102. View

Scherer J, Vallee R . Adenovirus recruits dynein by an evolutionary novel mechanism involving direct binding to pH-primed hexon. Viruses. 2011; 3(8):1417-31. PMC: 3185799. DOI: 10.3390/v3081417. View

Wickham T, Filardo E, Cheresh D, Nemerow G . Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol. 1994; 127(1):257-64. PMC: 2120185. DOI: 10.1083/jcb.127.1.257. View

Moyer C, Wiethoff C, Maier O, Smith J, Nemerow G . Functional genetic and biophysical analyses of membrane disruption by human adenovirus. J Virol. 2011; 85(6):2631-41. PMC: 3067937. DOI: 10.1128/JVI.02321-10. View

Seidman M, Hogan S, Wendland R, Worgall S, Crystal R, Leopold P . Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle. Mol Ther. 2001; 4(1):13-21. DOI: 10.1006/mthe.2001.0414. View

Fukaya T, Gondaira T, Kashiyae Y, Kotani S, Ishikura Y, Fujikawa S . Arachidonic acid preserves hippocampal neuron membrane fluidity in senescent rats. Neurobiol Aging. 2006; 28(8):1179-86. DOI: 10.1016/j.neurobiolaging.2006.05.023. View

Schroers R, Hildebrandt Y, Hasenkamp J, Glass B, Lieber A, Wulf G . Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors. Exp Hematol. 2004; 32(6):536-46. DOI: 10.1016/j.exphem.2004.03.010. View

10.

Seth P . Adenovirus-dependent release of choline from plasma membrane vesicles at an acidic pH is mediated by the penton base protein. J Virol. 1994; 68(2):1204-6. PMC: 236562. DOI: 10.1128/JVI.68.2.1204-1206.1994. View

11.

Arispe N, Doh M . Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB J. 2002; 16(12):1526-36. DOI: 10.1096/fj.02-0829com. View

12.

Huang S, Endo R, Nemerow G . Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol. 1995; 69(4):2257-63. PMC: 188895. DOI: 10.1128/JVI.69.4.2257-2263.1995. View

13.

Lai C, Hopwood L, Swartz H . Electron spin resonance studies of changes in membrane fluidity of Chinese hamster ovary cells during the cell cycle. Biochim Biophys Acta. 1980; 602(1):117-26. DOI: 10.1016/0005-2736(80)90294-1. View

14.

Wiethoff C, Wodrich H, Gerace L, Nemerow G . Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol. 2005; 79(4):1992-2000. PMC: 546575. DOI: 10.1128/JVI.79.4.1992-2000.2005. View

15.

Hall K, Blair Zajdel M, Blair G . Unity and diversity in the human adenoviruses: exploiting alternative entry pathways for gene therapy. Biochem J. 2010; 431(3):321-36. DOI: 10.1042/BJ20100766. View

16.

Kawamura Y, Adachi Y, Curiel D, Kawashima R, Kannagi R, Nishimoto N . Therapeutic adenoviral gene transfer of a glycosyltransferase for prevention of peritoneal dissemination and metastasis of gastric cancer. Cancer Gene Ther. 2014; 21(10):427-33. DOI: 10.1038/cgt.2014.46. View

17.

Tennant R, Layman K, Hand R . Effect of cell physiological state on infection by rat virus. J Virol. 1969; 4(6):872-8. PMC: 375951. DOI: 10.1128/JVI.4.6.872-878.1969. View

18.

Short J, Vasu C, Holterman M, Curiel D, Pereboev A . Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors. Virus Res. 2006; 122(1-2):144-53. PMC: 2203219. DOI: 10.1016/j.virusres.2006.07.009. View

19.

Vincent T, Pettersson R, Crystal R, Leopold P . Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells. J Virol. 2004; 78(15):8047-58. PMC: 446122. DOI: 10.1128/JVI.78.15.8047-8058.2004. View

20.

Kalin S, Amstutz B, Gastaldelli M, Wolfrum N, Boucke K, Havenga M . Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J Virol. 2010; 84(10):5336-50. PMC: 2863792. DOI: 10.1128/JVI.02494-09. View